From Healthcare & Pharma and USA - 9 Dec 2014 09:18 EST Merck acquisition marred by court ruling Add to My Stories Print page Add to Favourites Described by analysts at Leerink as a “very tough start to a relatively sound strategic deal,” Merck’s US$9.5bn plan to acquire the US biopharmaceutical group Cubist Pharmaceuticals, was dealt a…